SEC Form 4 · accession 0001225208-17-005441
BOSTON SCIENTIFIC CORP · BSX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph Michael Fitzgerald
Officer — EVP & President, CRM
Period of report
Feb 28, 2017
Accepted (ET)
Mar 2, 2017 · 7:30 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000885725
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Feb 28, 2017 | A | 47,782 | $0.00 | A | 159,970 | D | |
| Common StockF3,F2 | Feb 28, 2017 | M | 6,089 | $0.00 | A | 166,059 | D | |
| Common StockF2 | Feb 28, 2017 | F | 25,943 | $24.55 | D | 140,116 | D | |
| Common StockF4 | holding | — | — | — | 68,589 | I | By 401(k) |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Deferred Stock UnitsF6,F3,F5 | — | Feb 28, 2017 | M | 6,089 | D | — | — | Common Stock | 6,089 | 6,090 | D |
Explanation of responses
- F1On February 24, 2014, the reporting person was awarded a target number of performance share units under the Company's 2014 Total Shareholder Return Performance Share Program, the actual number of which to be earned by the reporting person was based on the Company's total shareholder return performance percentile relative to that of the other companies in the S&P 500 Healthcare Index over the three annual performance cycles comprising the three-year period ended December 31, 2016 and was subject to the completion of the concurrent three-year individual service period. On February 28, 2017, the number of the target performance share units as to which the performance criteria had been satisfied was determined and the individual service period was satisfied.
- F2Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.
- F3Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
- F4Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan.
- F5Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 28, 2014, the first anniversary of the date of grant.
- F6Reflects multiple DSU awards with independent vesting schedules.